MedPath

Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service

Not Applicable
Completed
Conditions
Menstrual Regulation
Interventions
Device: Semi-quantitative pregnancy test
Registration Number
NCT01954069
Lead Sponsor
Gynuity Health Projects
Brief Summary

The study seeks to test whether it is feasible and acceptable for both women and providers (in this context the Lady Health Visitor) to use the semi-quantitative pregnancy test (SQPT) as a tool for follow up after MR services. The study is planned at 11service delivery points (primary health clinics) in Punjab province where consenting women will be asked to take a baseline test at the clinic the morning they present for the MR procedure. Women will be asked to complete a second test at home the morning of their scheduled follow up visit and return to the clinic for follow-up care later that day. The results of the at home test will be compared to the baseline to determine the outcome of the MR. This is of particular importance because to-date no research has documented the accuracy of the test in detecting MR outcomes with misoprostol only regimens.

We hypothesize that women and providers will find the test easy and acceptable to use thereby improving follow up and simplifying MR service provision. In addition, the simple pictorial instructions will enable most women to use the test and interpret the results correctly on their own.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
280
Inclusion Criteria
  • Eligible for medical menstrual regulation services according to clinic guidelines
  • Willing to follow instructions and use the SQPT at home
  • Agrees to return for a follow-up visit 7 days after receipt of misoprostol for the MR procedure
Exclusion Criteria
  • Not eligible for medical menstrual regulation services according to clinic guidelines
  • Not willing to follow instructions and use the SQPT at home
  • Does not agree to return for a follow-up visit 7 days after receipt of misoprostol for the MR procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Semi-quantitative pregnancy testSemi-quantitative pregnancy testSemi-quantitative urine pregnancy test (SQPT) (dBest One Step hCG Panel Test Kit)
Primary Outcome Measures
NameTimeMethod
Feasibility to determine successful completion of MR2 weeks

1. The proportion of woman for whom Human Chorionic Gonadotropin (hCG) remains the same after MR

2. The proportion of woman for whom hCG remains increases after MR

3. The proportion of woman for whom hCG declines after MR

4. Any additional care received by women in each of the above groups (1-3) will also be described

Secondary Outcome Measures
NameTimeMethod
Comprehension of pregnancy test2 weeks

Proportion of women who correctly read and interpreted their results

Confidence in test2 weeks

Proportion of women who were confident in using the test and would be willing to use it for follow up in the future

Selecting and receiving family planning method2 weeks

Proportion of women selecting a method of family planning and receiving that method at their initial clinic visit.

Trial Locations

Locations (11)

BagaSher Service Delivery Clinic

🇵🇰

BagaSher, Muzaffargarh, Pakistan

Dasrat Colony Service Delivery Clinic

🇵🇰

Dasrat Colony, Muzaffargarh, Pakistan

Bahari Colony Service Delivery Clinic

🇵🇰

Bahari Colony, Rawalpindi, Pakistan

Karrila Service Delivery Clinic

🇵🇰

Karrila, Chakwal, Pakistan

Fazal Nagal Service Delivery Clinic

🇵🇰

Fazal Nagal, Muzaffargarh, Pakistan

TibbiAryain Service Delivery Clinic

🇵🇰

TibbiAryain, Muzaffargarh, Pakistan

Khanpur Service Delivery Clinic

🇵🇰

Khanpur, Chakwal, Pakistan

Bhagwal Service Delivery Clinic

🇵🇰

Bhagwal, Chakwal, Pakistan

Chakumra Service Delivery Clinic

🇵🇰

Chakumra, Chakwal, Pakistan

DhokeHasso Service Delivery Clinic

🇵🇰

DhokeHasso, Rawalpindi, Pakistan

Chak 128 GB Service Delivery Clinic

🇵🇰

Faisalabad, Pakistan

© Copyright 2025. All Rights Reserved by MedPath